Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.
3.
4.

Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy.

Kjeldsen SE, Strand A, Julius S, Okin PM.

J Clin Hypertens (Greenwich). 2006 Jul;8(7):487-92. Review.

5.

Angiotensin II receptor antagonists in arterial hypertension.

Hernández-Hernández R, Velasco M, Armas-Hernández MJ, Armas-Padilla MC.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S69-72. Review.

PMID:
10854084
6.
7.

Ventricular hypertrophy and hypertension: prognostic elements and implications for management.

Krauser DG, Devereux RB.

Herz. 2006 Jun;31(4):305-16. Review.

PMID:
16810470
8.

[Hypertension in patients with cardiac hypertrophy].

Kohno M.

Nihon Rinsho. 2004 Mar;62 Suppl 3:471-7. Review. Japanese. No abstract available.

PMID:
15171418
9.

[Regression of left ventricular hypertrophy in hypertensive patients].

Bosa Ojeda F, García González M, Domínguez Rodríguez A, Barragán Acea A, Miralles Ibarra JM, Lacalzada Almeida J, de Armas Trujillo D.

Rev Esp Cardiol. 1997;50 Suppl 4:74-6. Review. Spanish.

10.

Lisinopril in the treatment of hypertension.

Messerli FH, Kaesser UR.

J Hum Hypertens. 1989 Jun;3 Suppl 1:17-21. Review.

PMID:
2550640
11.

The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy.

Dahlöf B.

J Hypertens Suppl. 1993 Apr;11(3):S29-35. Review.

PMID:
8315516
12.

[Is reversal of left ventricular hypertrophy a priority in patients with hypertension?].

Plouin PF.

Arch Mal Coeur Vaiss. 1995 Feb;88 Spec No 2:49-53. Review. French.

PMID:
7646312
13.

[Angiotensin converting enzyme inhibitors in arterial hypertension].

Ramón González-Juanatey J.

Rev Esp Cardiol. 1999;52 Suppl 3:73-8. Review. Spanish.

14.

Enalapril: benefit-to-risk ratio in hypertensive patients.

Gomez HJ, Cirillo VJ, Smith SG 3rd.

J Cardiovasc Pharmacol. 1990;15 Suppl 3:S26-9. Review.

PMID:
1691415
15.

Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.

He YM, Feng L, Huo DM, Yang ZH, Liao YH.

Nephrology (Carlton). 2013 Sep;18(9):605-14. doi: 10.1111/nep.12134. Review.

PMID:
23869492
16.

[ACE inhibitor therapy of hemodialyzed patients].

Pató E, Radó J.

Orv Hetil. 1997 Jul 27;138(30):1903-7. Review. Hungarian.

PMID:
9289689
17.

[Regression of left ventricular hypertrophy in essential arterial hypertension].

Román O.

Rev Med Chil. 1994 Mar;122(3):333-8. Review. Spanish.

PMID:
7809527
18.

Angiotensin II antagonists: efficacy, duration of action, comparison with other drugs.

Elliott HL.

J Hum Hypertens. 1998 May;12(5):271-4. Review.

PMID:
9655646
19.

Losartan versus ACE inhibitors in the treatment of hypertension.

Jiang YC, Markind JE.

Ann Pharmacother. 1997 Nov;31(11):1388-91. Review. No abstract available.

PMID:
9391695
20.

Anti-hypertensive drugs have different effects on ventricular hypertrophy regression.

Ferreira Filho C, Abreu LC, Valenti VE, Ferreira M, Meneghini A, Silveira JA, Riera AR, Colombari E, Murad N, Santos-Silva PR, Silva LJ, Vanderlei LC, Carvalho TD, Ferreira C.

Clinics (Sao Paulo). 2010 Jul;65(7):723-8. doi: 10.1590/S1807-59322010000700012. Review.

Supplemental Content

Support Center